Serum levels of angiogenic factors and their prognostic relevance in bladder cancer

Pathology and Oncology Research

Volumn 15, Issue 2, 2009, Pages 193-201

  Szarvas, Tibor ^a   Jäger, Tobias ^a   Droste, Falk ^a   Becker, Markus ^a   Kovalszky, Ilona ^b   Romics, Imre ^c   Ergün, Süleyman ^d   Rübben, Herbert ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c SEMMELWEIS UNIVERSITY   (Hungary)

^d UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Angiopoietin; Bladder cancer; Prognosis; Serum; Tie2; VEGF

Indexed keywords

ANGIOGENIC FACTOR; ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; VASCULOTROPIN; ANGIOPOIETIN; TUMOR MARKER; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BLADDER CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; PROGNOSIS; RISK FACTOR; BLADDER TUMOR; BLOOD; CANCER STAGING; MIDDLE AGED; MUSCLE TUMOR; PATHOLOGY; SURVIVAL RATE; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPOIETINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RECEPTOR, TIE-2; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 68949092308     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12253-008-9107-z     Document Type: Article

References (37)

1. N Weidner JP Semple WR Welch J Folkman 1991 Tumor angiogenesisand metastasis correlation in invasive breast carcinoma N Engl J Med 324 1 8 1:STN:280:DyaK3M%2FnsVWquw%3D%3D 1701519
2. S Davis TH Aldrich PF Jones A Acheson DL Compton V Jain TE Ryan J Bruno C Radziejewski PC Maisonpierre GD Yancopoulos 1996 Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning Cell 87 1161 1169 10.1016/S0092-8674(00)81812-7 1:CAS:528:DyaK2sXit1Cqsw%3D%3D 8980223 (Pubitemid 27010100)
3. A Papapetropoulos G Garcia-Cardena TJ Dengler PC Maisonpierre GD Yancopoulos WC Sessa 1999 Direct actions of angiopoietin-1 on human endothelium: evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors Lab Invest 79 213 223 1:CAS:528:DyaK1MXhsl2jurY%3D 10068209
4. PC Maisonpierre C Suri PF Jones S Bartunkova SJ Wiegand C Radziejewski D Compton J McClain TH Aldrich N Papadopoulos TJ Daly S Davis TN Sato GD Yancopoulos 1997 Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis Science 277 55 60 10.1126/science.277.5322.55 1:CAS:528:DyaK2sXksVyhu78%3D 9204896 (Pubitemid 27450643)
5. J Holash PC Maisonpierre D Compton P Boland CR Alexander D Zagzag GD Yancopoulos SJ Wiegand 1999 Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF Science 284 1994 1998 10.1126/science.284. 5422.1994 1:CAS:528:DyaK1MXktVWntrY%3D 10373119 (Pubitemid 29309448)
6. M Volm R Koomagi J Mattern 1997 Prognostic value of vascular endothelial growth factor and its receptor flt-1 in squamous cell lung cancer Int J Cancer 74 64 68 10.1002/(SICI)1097-0215(19970220)74:1<64::AID-IJC11>3.0.CO;2-I 1:STN:280:DyaK2s7ovVartA%3D%3D 9036871 (Pubitemid 27157857)
7. K Inoue Y Ozeki T Suganuma Y Sugiura S Tanaka 1997 Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma Cancer 79 206 213 10.1002/(SICI)1097-0142(19970115)79:2<206::AID-CNCR2>3.0.CO;2-I 1:STN:280:DyaK2s7mtlamtQ%3D%3D 9010092 (Pubitemid 27029883)
8. K Maeda Y Chung S Takatsuka Y Ogawa T Sawada Y Yamashita, et al. 1995 Tumor angiogenesis as a predictor of recurrence in gastric carcinoma J Clin Oncol 13 477 481 1:STN:280:DyaK2M7kslSgtA%3D%3D 7531224
9. C Dosquet MC Coudert E Lepage J Cabane F Richard 1997 Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma? Clin Cancer Res 3 2451 2458 1:CAS:528:DyaK1cXisV2quw%3D%3D 9815646
10. F Tas D Duranyildiz H Oguz H Camlica V Yasasever E Topuz 2006 Circulating serum levels of angiogenic factors and vascular endothelial growth factor receptors 1 and 2 in melanoma patients Melanoma Res 16 405 411 10.1097/01.cmr.0000222598.27438.82 1:CAS:528:DC%2BD28XhtVWntr7J 17013089 (Pubitemid 44511220)
11. S Bernardini S Fauconnet E Chabannes PC Henry G Adessi H Bittard 2001 Serum levels of vascular endothelial growth factor as a prognostic factor in bladder cancer J Urol 166 1275 1279 10.1016/S0022-5347(05)65752-7 1:CAS:528:DC%2BD3MXptVKks7g%3D 11547057
12. C Sfiligoi A de Luca I Cascone V Sorbello L Fuso R Ponzone N Biglia E Audero R Arisio F Bussolino P Sismondi M De Bortoli 2003 Angiopoietin-2 expression in breast cancer correlates with lymph node invasion and short survival Int J Cancer 103 466 474 10.1002/ijc.10851 1:CAS:528: DC%2BD3sXhvVOjuw%3D%3D 12478661 (Pubitemid 36020220)
13. JH Wurmbach P Hammerer S Sevinc H Huland S Ergun 2000 The expression of angiopoietins and their receptor Tie-2 in human prostate carcinoma Anticancer Res 20 5217 5220 1:CAS:528:DC%2BD3MXjsVWksr0%3D 11326698
14. MP Wong SY Chan KH Fu SY Leung N Cheung ST Yuen LP Chung 2000 The angiopoietins, tie2 and vascular endothelial growth factor are differentially expressed in the transformation of normal lung to non-small cell lung carcinomas Lung Cancer 29 11 22 10.1016/S0169-5002(00)00118-5 1:STN:280: DC%2BD3cvgvFOltQ%3D%3D 10880843
15. K Hata K Nakayama R Fujiwaki H Katabuchi H Okamura K Miyazaki 2004 Expression of the angopoietin-1, angopoietin-2, Tie2, and vascular endothelial growth factor gene in epithelial ovarian cancer Gynecol Oncol 93 215 222 10.1016/j.ygyno.2003.12.031 1:CAS:528:DC%2BD2cXisFylurc%3D 15047239 (Pubitemid 38429573)
16. R Liersch C Schliemann R Bieker H Hintelmann T Buechner WE Berdel RM Mesters 2008 Expression of VEGF-C and its receptor VEGFR-3 in the bone marrow of patients with acute myeloid leukaemia Leuk Res 32 954 961 10.1016/j.leukres. 2007.10.005 1:CAS:528:DC%2BD1cXjs1Slt7o%3D 18006056
17. R Liersch C Schliemann R Bieker H Hintelmann T Buechner WE Berdel RM Mesters 2008 Expression of VEGF-C and its receptor VEGFR-3 in the bone marrow of patients with acute myeloid leukaemia Leuk Res 32 954 961 10.1016/j.leukres. 2007.10.005 1:CAS:528:DC%2BD1cXjs1Slt7o%3D 18006056
18. JH Park KJ Park YS Kim SS Sheen KS Lee HN Lee YJ Oh SC Hwang 2007 Serum angiopoietin-2 as a clinical marker for lung cancer Chest 132 200 206 10.1378/chest.06-2915 1:CAS:528:DC%2BD2sXovFKlurk%3D 17505039 (Pubitemid 47068222)
19. CE Lewis M De Palma L Naldini 2007 Tie2-expressing monocytes and tumor angiogenesis: regulation by hypoxia and angiopoietin-2 Cancer Res 67 8429 8432 10.1158/0008-5472.CAN-07-1684 1:CAS:528:DC%2BD2sXhtVCit7%2FE 17875679 (Pubitemid 47437413)
20. P Reusch B Barleon K Weindel G Martiny-Baron A Gödde G Siemeister D Marmé 2001 Identification of a soluble form of the angiopoietin receptor TIE-2 released from endothelial cells and present in human blood Angiogenesis 4 123 131 10.1023/A:1012226627813 1:CAS:528:DC%2BD38XovV2nug%3D%3D 11806244 (Pubitemid 34032698)
21. Eble JN, Epstein JI, Sesterhenn I, World Health Organization classification of tumors (2004) Pathology and genetics of tumors of the urinary system and male genital organs. IARCC, Lyon, pp 89-158
22. C Suri PF Jones S Patan S Bartunkova PC Maisonpierre S Davis TN Sato GD Yancopoulos 1996 Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis Cell 87 1171 1180 10.1016/S0092-8674(00) 81813-9 1:CAS:528:DyaK2sXit1GhtQ%3D%3D 8980224 (Pubitemid 27010101)
23. J Holash SJ Wiegand GD Yancopoulos 1999 New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF Oncogene 18 5356 5362 10.1038/sj.onc.1203035 1:CAS:528: DyaK1MXms1Ontr0%3D 10498889 (Pubitemid 29462372)
24. JP Crew S Fuggle R Bicknell DW Cranston A de Benedetti AL Harris 2000 Eukaryotic initiation factor-4E in superficial and muscle invasive bladder cancer and its correlation with vascular endothelial growth factor expression and tumour progression Br J Cancer 82 161 166 10.1054/bjoc.1999.0894 1:CAS:528:DC%2BD3cXltFWktA%3D%3D 10638984
25. T O'Brien D Cranston S Fuggle R Bicknell AL Harris 1995 Different angiogenic pathways characterize superficial and invasive bladder cancer Cancer Res 55 510 513 7530595
26. T Quentin T Schlott M Korabiowska N Kathei G Zoller F Glaser E Kunze 2004 Alteration of the vascular endothelial growth factor and angiopoietins-1 and -2 pathways in transitional cell carcinomas of the urinary bladder associated with tumor progression Anticancer Res 24 2745 2756 1:CAS:528:DC%2BD2cXhtVSjsLrP 15517881
27. L Oliveira-Ferrer D Tilki G Ziegeler J Hauschild S Loges S Irmak E Kilic H Huland M Friedrich S Ergün 2004 Dual role of carcinoembryonic antigen-related cell adhesion molecule 1 in angiogenesis and invasion of human urinary bladder cancer Cancer Res 64 8932 8938 10.1158/0008-5472.CAN-04-0505 1:CAS:528:DC%2BD2cXhtVOmsL3E 15604255 (Pubitemid 39665500)
28. WD Beecken T Engl J Hofmann D Jonas R Blaheta 2005 Clinical relevance of serum angiogenic activity in patients with transitional cell carcinoma of the bladder J Cell Mol Med 9 655 661 10.1111/j.1582-4934.2005.tb00495.x 1:CAS:528:DC%2BD2sXlvFCksr0%3D 16202212
29. CR Tait PF Jones 2004 Angiopoietins in tumours: the angiogenic switch J Pathol 204 1 10 10.1002/path.1618 1:CAS:528:DC%2BD2cXot1alsLo%3D 15307132 (Pubitemid 39214476)
30. N Oka Y Yamamoto M Takahashi M Nishitani HO Kanayama S Kagawa 2005 Expression of angiopoietin-1 and -2, and its clinical significance in human bladder cancer BJU Int 95 660 663 10.1111/j.1464-410X.2005.05358.x 1:CAS:528:DC%2BD2MXis1Kgs7s%3D 15705099 (Pubitemid 40311493)
31. C Schliemann R Bieker N Thoennissen J Gerss R Liersch T Kessler T Büchner WE Berdel RM Mesters 2007 Circulating angiopoietin-2 is a strong prognostic factor in acute myeloid leukemia Leukemia 21 1901 1906 10.1038/sj.leu.2404820 1:CAS:528:DC%2BD2sXptlSrs7c%3D 17597808 (Pubitemid 47299962)
32. JH Park KJ Park YS Kim SS Sheen KS Lee HN Lee YJ Oh SC Hwang 2007 Serum angiopoietin-2 as a clinical marker for lung cancer Chest 132 200 206 10.1378/chest.06-2915 1:CAS:528:DC%2BD2sXovFKlurk%3D 17505039 (Pubitemid 47068222)
33. CE Lewis M De Palma L Naldini 2007 Tie2-expressing monocytes and tumor angiogenesis: regulation by hypoxia and angiopoietin-2 Cancer Res 67 8429 8432 10.1158/0008-5472.CAN-07-1684 1:CAS:528:DC%2BD2sXhtVCit7%2FE 17875679 (Pubitemid 47437413)
34. P Reusch B Barleon K Weindel G Martiny-Baron A Gödde G Siemeister D Marmé 2001 Identification of a soluble form of the angiopoietin receptor TIE-2 released from endothelial cells and present in human blood Angiogenesis 4 123 131 10.1023/A:1012226627813 1:CAS:528:DC%2BD38XovV2nug%3D%3D 11806244 (Pubitemid 34032698)
35. AL Harris P Reusch B Barleon C Hang N Dobbs D Marme 2001 Soluble Tie2 and Flt1 extracellular domains in serum of patients with renal cancer and response to antiangiogenic therapy Clin Cancer Res 7 1992 1997 1:CAS:528: DC%2BD3MXlslalurg%3D 11448916
36. CM Findley MJ Cudmore A Ahmed CD Kontos 2007 VEGF induces Tie2 shedding via a phosphoinositide 3-kinase/Akt dependent pathway to modulate Tie2 signaling Arterioscler Thromb Vasc Biol 27 2619 2626 10.1161/ATVBAHA.107.150482 1:CAS:528:DC%2BD2sXhtlahtLrN 17901375 (Pubitemid 350158914)
37. P Lin P Polverini M Dewhirst S Shan PS Rao K Peters 1997 Inhibition of tumor angiogenesis using a soluble receptor establishes a role for Tie2 in pathologic vascular growth J Clin Invest 100 2072 2078 10.1172/JCI119740 1:CAS:528:DyaK2sXmslKkurk%3D 9329972